Animal Health International, Inc.

Animal Health International, Inc. Animal Health Holdings, Inc. Division, doing business as Lextron Animal Health, supplies equine vaccines and animal health products to the Department of the Interior's Bureau of Land Management as a prime contractor under full and open competition, with no SBA set-aside designations across its federal footprint. The company is a subsidiary of Patterson Companies, Inc., a diversified healthcare and veterinary supply provider headquartered in Mendota Heights, Minnesota. Lextron operates from facilities in Loveland and Greeley, Colorado, and Phoenix, Arizona, manufacturing biologicals and veterinary pharmaceuticals under NAICS codes spanning Medicinal and Botanical Manufacturing, Pharmaceutical Preparation Manufacturing, and Biological Product Manufacturing, with primary PSC alignment to Drugs and Biologicals, Veterinary Use.

Lextron's federal customer base concentrates almost entirely on the Department of the Interior Bureau of Land Management National Office, which accounts for 25 awards (88% of all awards by count) and $50.3 million in combined potential value (100% of all dollars). The BLM relationship anchors around the Wild Horse and Burro Program, which manages health and vaccination for federally protected wild equine populations across western public lands. Secondary customers include the Department of Agriculture Agricultural Research Service (13 awards, $113 thousand), the Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services (3 awards, $75 thousand), and small veterinary-supply orders to the Federal Bureau of Prisons at Lompoc and El Reno facilities totaling roughly $26 thousand. Activity has declined sharply since 2022 — eight awards that year, tapering to three in 2026 — reflecting the maturity of the underlying BLM vehicle rather than new customer wins.

Lextron holds two indefinite delivery contracts with BLM. The primary vehicle, awarded October 1, 2022, carries a $20 million ceiling running through September 30, 2027, and has generated 12 delivery orders totaling $6.6 million in combined potential value. The second vehicle, Indefinite Delivery Contract 140L0122D0010, has produced 7 task orders valued at $12.3 million. Representative recent orders include a $2.99 million delivery order issued September 24, 2026, a $980 thousand order from May 22, 2026 (modified from $949 thousand), a $751 thousand order from March 12, 2026, and a $2.95 million order from August 28, 2024, all for wild horse and burro vaccines under firm fixed-price terms. Only two awards (combined potential value $4 million) face recompete inside the next twenty-four months. Lextron operates exclusively as a prime contractor across its federal footprint with no subcontract work tracked in the source data.